Vivimed Labs Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 442.24 million compared to INR 543.75 million a year ago. Revenue was INR 443.74 million compared to INR 545.18 million a year ago. Net loss was INR 220.31 million compared to INR 232.99 million a year ago. Basic loss per share from continuing operations was INR 2.66 compared to INR 2.81 a year ago.
For the six months, sales was INR 943.3 million compared to INR 1,196.35 million a year ago. Revenue was INR 945.62 million compared to INR 1,206.93 million a year ago. Net loss was INR 442.34 million compared to INR 256.35 million a year ago. Basic loss per share from continuing operations was INR 5.33 compared to INR 3.09 a year ago.